Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3065

Actual shortage: 232 (8%)
Anticipated shortage: 15 (0%)
Avoided shortage: 9 (0%)
Resolved: 2809 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

30 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-09 178772
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-20 178775
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2022-12-16 2023-02-02 178778
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2022-12-16 2023-02-02 178781
APO-ARIPIPRAZOLE 30MG TABLET Resolved 2022-12-16 2023-03-30 178784
APO-ARIPIPRAZOLE 30MG TABLET Resolved 2022-12-16 2023-03-30 178787
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2022-12-16 2023-03-02 178790
APO-AMLODIPINE-ATORVASTATIN 80MG 5MG TABLET Resolved 2022-12-16 2023-03-02 178793
APO-AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Resolved 2022-12-23 2023-03-23 179437
APO-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Resolved 2022-12-23 2023-03-16 179441
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-23 2023-03-02 179444
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-23 2023-03-02 179447
APO-FLECAINIDE 50MG TABLET Resolved 2022-12-23 2023-01-13 179450
APO-FLUVOXAMINE 50MG TABLET Resolved 2022-12-23 2023-02-17 179453
APO-OXYBUTYNIN 5MG TABLET Resolved 2022-12-23 2023-01-26 179456
APO-PRAVASTATIN 20MG TABLET Resolved 2022-12-23 2023-01-20 179459
APO-DIVALPROEX 250MG TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) Resolved 2023-01-06 2023-01-20 180081
APO-SOTALOL 80MG TABLET Resolved 2023-01-06 2023-02-16 180086
APO-SOTALOL 160MG TABLET Resolved 2023-01-06 2023-02-16 180093
APO-VERAP TABLET 120MG 120MG TABLET Resolved 2023-01-06 2023-03-02 180106

Showing 2281 to 2300 of 3065

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ACEBUTOLOL 400MG TABLET Discontinued 2017-03-31 2018-02-05 4965
APO-OLANZAPINE 5.0MG TABLET Discontinued 2017-03-31 2018-02-05 4968
APO-SOTALOL 160MG TABLET Discontinued 2017-03-31 2018-02-05 4971
APO-TERAZOSIN 2MG TABLET Discontinued 2017-03-31 2018-02-05 4974
APO-DOCUSATE SODIUM 100MG CAPSULE Discontinued 2018-02-23 2019-03-29 40733
DOCUSATE SODIUM CAPSULES 100MG CAPSULE Discontinued 2018-02-23 2018-09-15 40738
APO-FENTANYL MATRIX 100MCG PATCH Discontinued 2018-02-23 2018-12-28 40741
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-02-23 40757
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-07-17 40760
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40766
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40769
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2019-06-12 40778
APO-METFORMIN 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40781
APO-METFORMIN 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40784
APO-METFORMIN 500MG TABLET Discontinued 2018-02-23 2018-11-26 40790
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2018-09-15 40796
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2018-02-23 2019-09-12 40805
APO-TELMISARTAN 40MG TABLET Discontinued 2018-02-23 2018-09-15 40811
APO-TELMISARTAN 40MG TABLET Discontinued 2018-02-23 2018-09-15 40814

Showing 41 to 60 of 356